drug pairs 
http://bio2rdf.org/drugbank:DB01233-http://bio2rdf.org/drugbank:DB00390    object:DIGOXIN precipitant: METOCLOPRAMIDE 	DDI-Corpus-2013 Evidence: Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). |  	PK-Corpus Evidence: Absorption of drugs from the stomach may be diminished |  	NLM-Corpus Evidence: Decrease_Interaction 
http://bio2rdf.org/drugbank:DB01045-http://bio2rdf.org/drugbank:DB00612    object:RIFAMPIN precipitant: Zebeta 	DDI-Corpus-2013 Evidence: Concurrent use of rifampin increases the metabolic clearance of ZEBETA, resulting in a shortened elimination half-life of ZEBETA.|  	PK-Corpus Evidence: increases the metabolic clearance of bisoprolol fumarate shortening its elimination half-life |  	NLM-Corpus Evidence: Decrease_Interaction 
